{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:47:12Z","timestamp":1784825232333,"version":"3.55.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183861","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T13:27:56Z","timestamp":1504272476000},"page":"e0183861","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System\u00ae for the treatment of hepatocellular carcinoma"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1056-4945","authenticated-orcid":true,"given":"Alexander Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"DeMulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Caridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Emmett","family":"Lynskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival","volume":"37","author":"JM Llovet","year":"2003","journal-title":"Hepatol Baltim Md"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"JM Llovet","year":"2002","journal-title":"Lancet Lond Engl"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"C-M Lo","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"FY Yao","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"ref5","first-page":"449","article-title":"Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization","volume":"10","author":"YK Maddala","year":"2004","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"ref6","first-page":"272","article-title":"Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma","volume":"13","author":"G Millonig","year":"2007","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","article-title":"Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis","volume":"35","author":"K Malagari","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"J Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jhep.2015.01.022","article-title":"Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma","volume":"62","author":"BK Kim","year":"2015","journal-title":"J Hepatol"},{"key":"ref10","first-page":"826","article-title":"Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation","volume":"49","author":"BK Kim","year":"2013","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"R Golfieri","year":"2014","journal-title":"Br J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2015.64.0821","article-title":"Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone","volume":"34","author":"KT Brown","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000371522","article-title":"Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial","volume":"89","author":"B Liu","year":"2015","journal-title":"Oncology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"v153","DOI":"10.1093\/annonc\/mdj972","article-title":"Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature","volume":"17","author":"D Pastorelli","year":"2006","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejrad.2008.08.007","article-title":"Review on transarterial chemoembolization in hepatocellular carcinoma: Palliative, combined, neoadjuvant, bridging, and symptomatic indications","volume":"72","author":"TJ Vogl","year":"2009","journal-title":"Eur J Radiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jvir.2012.11.023","article-title":"Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles","volume":"24","author":"SA Padia","year":"2013","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jvir.2009.10.038","article-title":"Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma","volume":"21","author":"A Nicolini","year":"2010","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","article-title":"Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis","volume":"35","author":"K Malagari","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2214\/AJR.10.4379","article-title":"Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: Results from the PRECISION V randomized trial","volume":"197","author":"TJ Vogl","year":"2011","journal-title":"Am J Roentgenol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jvir.2012.12.018","article-title":"Quantification and reduction of reflux during embolotherapy using an antireflux catheter and tantalum microspheres: ex vivo analysis","volume":"24","author":"A Arepally","year":"2013","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jvir.2015.01.029","article-title":"The impact of an antireflux catheter on target volume particulate distribution in liver-directed embolotherapy: a pilot study","volume":"26","author":"AS Pasciak","year":"2015","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jhep.2015.01.023","article-title":"Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?","volume":"63","author":"M-A Allard","year":"2015","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/PPO.0b013e3181c5214b","article-title":"Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States","volume":"15","author":"DK Reyes","year":"2009","journal-title":"Cancer J Sudbury Mass"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1148\/radiol.10091473","article-title":"Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort","volume":"255","author":"RJ Lewandowski","year":"2010","journal-title":"Radiology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00270-012-0476-z","article-title":"Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure","volume":"36","author":"T Irie","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2214\/AJR.10.4770","article-title":"Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma","volume":"196","author":"B Jin","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2214\/AJR.14.13683","article-title":"Feasibility of Intraprocedural Transluminal Hepatic and Femoral Artery Blood Pressure Measurements as an Alternative Embolization Safety Endpoint When Antireflux Devices Are Used During Lobar Chemoembolization","volume":"205","author":"SC Rose","year":"2015","journal-title":"Am J Roentgenol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T10:58:11Z","timestamp":1540292291000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183861"}},"subtitle":[],"editor":[{"given":"Sheng-Nan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183861","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}